317 related articles for article (PubMed ID: 11578642)
1. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
[TBL] [Abstract][Full Text] [Related]
2. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
[TBL] [Abstract][Full Text] [Related]
3. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression.
Watson S; Gallagher P; Del-Estal D; Hearn A; Ferrier IN; Young AH
Psychol Med; 2002 Aug; 32(6):1021-8. PubMed ID: 12214783
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
[TBL] [Abstract][Full Text] [Related]
6. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
Rybakowski JK; Twardowska K
J Psychiatr Res; 1999; 33(5):363-70. PubMed ID: 10504004
[TBL] [Abstract][Full Text] [Related]
7. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
Menke A; Arloth J; Best J; Namendorf C; Gerlach T; Czamara D; Lucae S; Dunlop BW; Crowe TM; Garlow SJ; Nemeroff CB; Ritchie JC; Craighead WE; Mayberg HS; Rex-Haffner M; Binder EB; Uhr M
Psychoneuroendocrinology; 2016 Jul; 69():161-71. PubMed ID: 27107207
[TBL] [Abstract][Full Text] [Related]
9. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
[TBL] [Abstract][Full Text] [Related]
10. The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
Zwanzger P; Baghai TC; Padberg F; Ella R; Minov C; Mikhaiel P; Schüle C; Thoma H; Rupprecht R
Psychoneuroendocrinology; 2003 Apr; 28(3):376-85. PubMed ID: 12573303
[TBL] [Abstract][Full Text] [Related]
11. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
12. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
Sher L
ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
[TBL] [Abstract][Full Text] [Related]
13. Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?
Rotvig DH; Jorgensen A; Jensen JH; Hansen AR; Eller NH; Jonsson SH; Knorr U; Klose MC; Feldt-Rasmussen U; Menke A; Poulsen HE; Bauer JØ; Jørgensen MB
Stress; 2024 Jan; 27(1):2353781. PubMed ID: 38823417
[TBL] [Abstract][Full Text] [Related]
14. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
Heuser I; Yassouridis A; Holsboer F
J Psychiatr Res; 1994; 28(4):341-56. PubMed ID: 7877114
[TBL] [Abstract][Full Text] [Related]
15. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
Sarubin N; Nothdurfter C; Schüle C; Lieb M; Uhr M; Born C; Zimmermannc R; Bühner M; Konopka K; Rupprecht R; Baghai TC
J Psychiatr Res; 2014 Jun; 53():76-83. PubMed ID: 24655586
[TBL] [Abstract][Full Text] [Related]
16. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease.
Hatzinger M; Z'Brun A; Hemmeter U; Seifritz E; Baumann F; Holsboer-Trachsler E; Heuser IJ
Neurobiol Aging; 1995; 16(2):205-9. PubMed ID: 7777138
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis.
Lopez-Duran NL; Kovacs M; George CJ
Psychoneuroendocrinology; 2009 Oct; 34(9):1272-83. PubMed ID: 19406581
[TBL] [Abstract][Full Text] [Related]
19. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.
Costa A; Bono G; Martignoni E; Merlo P; Sances G; Nappi G
Psychoneuroendocrinology; 1996 Apr; 21(3):263-75. PubMed ID: 8817725
[TBL] [Abstract][Full Text] [Related]
20. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
